Hydroxy-PEG20-Boc , CAS No.H1447200

CAS: H1447200 Cat. No.: H1447200 Formula: C47H94O23 Molecular Weight: 1027.24
AVAILABLE TO ORDER
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Size
Germany (EU)
USA*
Price
Qty
1mg
H1447200-1mg
Made to order · 8–12 wks
Enter a quantity for the sizes you want to add.

Overview

Hydroxy-PEG20-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

Specifications

Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
This product requires cold chain shipping. Ground and other economy services are not available.
Names and Identifiers
Molecular Weight
1027.24

Advanced Data

Certificates (CoA,COO,BSE/TSE and Analysis Chart)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Solution Calculators
Reviews

Customer Reviews

Application Protocols

No vendor-validated bioassay protocols are provided for this item. Typical research workflows (literature/general) include:

  • Boc deprotection protocol

    • Dissolve Hydroxy-PEG20-Boc in DCM (or DCM/TFE). Add 5–20 equiv TFA at 0–25°C. Stir 1–2 h. Evaporate solvents; co-evaporate with toluene to remove residual TFA. Neutralize if needed and proceed to coupling.
  • Hydroxyl activation and substitution

    • For mesylate formation: Cool solution in dry DCM; add Et3N, catalytic DMAP, then MsCl dropwise at 0°C; warm to RT and stir until complete. Quench, wash, and precipitate into cold ether.
    • For carbonate using CDI: Form imidazolyl carbonate in DCM/THF with CDI and DMAP; add nucleophile (amine/phenol) and stir to completion.
  • Conjugation to biomolecules (post-deprotection)

    • Dissolve amine-PEG20-OH in buffer (pH 7.5–8.5) with 5–20% DMF/DMSO as needed. Add activated ester partner; incubate 0.5–4 h at 4–25°C. Desalt by dialysis or SEC.

These are general, literature-style procedures provided for planning purposes only. Optimize conditions for your specific substrates and consult the SDS and CoA for item-specific constraints.

Biological Roles
  • General notes on PEGylation (literature/general; not product-specific claims)

    • Poly(ethylene glycol) chains are widely used in biochemical research to modulate hydrodynamic size, reduce nonspecific protein adsorption, and enhance aqueous solubility of conjugates. They can decrease surface fouling and improve stability of research probes and materials.
    • The Boc group temporarily masks the terminal amine, preventing premature reactions during multistep assembly. After deprotection, the primary amine can participate in amide/urea formation to attach ligands, dyes, or affinity tags for in vitro studies.
  • Use in biomaterials and assay systems

    • As a spacer between bioactive headgroups and surfaces (e.g., on beads, chips, or nanoparticles), PEG20 provides approximately 7–9 nm of contour length (literature estimate; ~0.35–0.45 nm per ethylene glycol unit), offering flexibility and reduced steric hindrance.
    • In protein and oligonucleotide research, PEG linkers can reduce aggregation and alter local crowding effects, aiding assay reproducibility.
  • Cautions

    • Avoid conflating PEG-mediated effects with intrinsic biological activity of a conjugated ligand; appropriate controls (e.g., non-PEGylated analogs) are recommended.
    • No clinical or therapeutic claims are made for this product; it is intended solely for laboratory research use.
Buffer Applications

Hydroxy-PEG20-Boc is not a buffering agent and does not establish a defined pH range. However, buffer selection is relevant for downstream bioconjugation after Boc removal.

  • Practical guidance (literature/general)

    • Boc deprotection is typically conducted in organic acid media (e.g., TFA in DCM) rather than aqueous buffers. Post-deprotection, residual acid is removed, and the product can be transferred into aqueous buffer.
    • For amide coupling of the resulting amine with activated esters: use phosphate, HEPES, or bicarbonate buffers at pH 7.5–8.5. Maintain ionic strength (50–150 mM) and include 5–20% DMF/DMSO if needed for solubility.
    • For NHS-ester conjugations, avoid Tris or other nucleophilic buffers that can quench activated esters.
  • Example buffer setups (general, not item specifications)

    • Phosphate buffer, 100 mM, pH 8.0 with 10% DMF for protein conjugations at 4–25°C.
    • Bicarbonate buffer, 100 mM, pH 8.3 for small-molecule coupling to surfaces.

Select buffers based on the reactivity of coupling partners and stability of biomolecules; this product itself does not provide buffering capacity.

Green Alternatives

While Hydroxy-PEG20-Boc itself is a reagent rather than a solvent, greener choices can be made for the processes employing it.

  • Greener solvent choices (literature/general)

    • Replace DCM with 2-MeTHF, CPME, or ethyl acetate where compatible (e.g., for Boc deprotections consider EtOAc/TFA or Toluene/TFA with careful control; note potential solubility differences).
    • Favor acetonitrile or dimethyl carbonate over DMF in some activation steps when reactivity permits; consider propylene carbonate as a high-boiling, less toxic polar aprotic alternative.
    • Use water/ethanol co-solvent systems for bioconjugations whenever stability allows.
  • Greener activation/coupling strategies

    • Carbonate activation with green phosgene equivalents (e.g., CDI) avoids chlorinated reagents; workup generates imidazole byproducts that are easier to handle than p-nitrophenyl wastes.
    • Enzymatic or aqueous carbodiimide couplings (e.g., EDC) after installing carboxyl handles onto the PEG chain can reduce reliance on harsher reagents.
  • Comparison snapshot (general)

    • DCM vs 2-MeTHF: DCM offers excellent solvency and volatility but is chlorinated and has higher environmental impact; 2-MeTHF is bio-based and less toxic but may not dissolve higher-MW PEGs as effectively without co-solvent.
    • DMF vs acetonitrile: DMF solvates PEGs very well but has reproductive toxicity concerns; acetonitrile is less hazardous but may require higher temperatures or catalysts.

Implement solvent-recycling, minimize excess coupling reagents, and design convergent routes to reduce waste with PEGylated constructs.

Pharmaceutical Uses

This product is supplied for research use only. No medical, diagnostic, or therapeutic uses are claimed.

  • General formulation roles of PEG linkers (literature/general)

    • PEG chains are employed in research-scale formulation development as hydrophilic spacers to adjust solubility, reduce aggregation, and tune rheology of prototype conjugates and materials.
    • Heterobifunctional PEGs (such as Hydroxy-PEG20-Boc) serve as intermediates to generate amine-terminated PEGs that can be attached to model actives, dyes, or surfaces for preformulation studies.
    • In solid-phase and solution-phase synthesis, PEG linkers can improve handling (reduced crystallinity) and facilitate purification by precipitation or solid-supported scavenging.
  • Regulatory notes (general)

    • Pharmaceutical excipient grades of PEGs exist with compendial monographs (e.g., USP/NF, Ph. Eur.) for certain average molecular weights and end-groups; however, this specific item’s compendial status, if any, is not specified for this item; refer to CoA/Spec Sheet.

All work should remain at non-clinical, laboratory scale unless appropriate regulatory and quality frameworks are established using qualified materials.

Physical Properties
  • Item-specific values (from Product Data)

    • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
  • Typical properties for PEGn linkers (literature/general; not product specifications)

    • Aggregated/average MW estimate for PEG20 backbones is commonly in the 900–1,100 g/mol range before end-group contributions; Boc end-group adds ~101 g/mol to the underlying amine functionality. Exact values depend on supplier and dispersity.
    • Physical state: PEG oligomers in this MW range often appear as waxy solids or highly viscous oils at ambient temperature; glass transition typically below room temperature; melting behavior can be broad due to polydispersity.
    • Solubility: Highly soluble in polar organic solvents (DMSO, DMF, NMP, MeOH, EtOH, acetonitrile); miscible with water to varying degrees depending on temperature and concentration. Limited solubility in nonpolar solvents (hexanes, toluene) unless aided by co-solvents.
    • LogP: Very low (PEGs are hydrophilic); increases modestly with protecting groups but remains in the hydrophilic regime.
    • pKa: Not applicable; the polymer lacks ionizable groups under neutral conditions. The Boc-protected amine is non-basic; after deprotection, the primary amine has pKaH ≈ 9–10 (literature for aliphatic primary amines).
    • Density/refractive index/viscosity: Typical PEG oligomers show densities near 1.1–1.2 g/mL and elevated viscosities; precise values depend on MW and temperature (literature trends only).

For definitive numerical specifications of this catalog item, please consult the CoA/Spec Sheet.

Quality and Grades
  • Item-specific quality information

    • Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.
  • Guidance for interpreting typical grades of PEG linkers (general; not product specifications)

    • Research grade: Suitable for most synthetic and screening applications; typical reporting includes average Mn/Mw and functional end-group assay.
    • High-purity/bioconjugation grade: Tighter control of dispersity (Ð), residual solvent content, and low levels of reactive impurities (peroxides, aldehydes). Often accompanied by NMR end-group analysis, SEC traces, and KF moisture.
    • HPLC grade (for solvents) is not applicable; however, “HPLC-pure” descriptions for linkers may indicate low UV-absorbing impurities beneficial for analytical tracking.
  • End-group integrity

    • For heterobifunctional PEGs, verification of both termini is critical. Common analyses: 1H/13C NMR (end-group integration), MALDI-TOF or ESI-MS (average mass envelope), SEC/GPC (dispersity), and functional assays (e.g., TNBS after Boc deprotection for free amine).
  • Stabilizers and additives

    • PEG linkers are typically supplied neat without stabilizers. If stabilizers are present in other products, they can interfere with coupling chemistry; absence/presence should be confirmed on the CoA.

Consult the CoA/Spec Sheet for the definitive purity, residual solvent/moisture, and analytical characterization specific to SKU H1447200.

Reaction and Applications

Hydroxy-PEG20-Boc is a versatile heterobifunctional spacer enabling orthogonal chemistry: the hydroxyl is available for derivatization while the amine is masked as a Boc carbamate.

  • Representative applications (literature/general)

    • Linker for PROTACs, molecular glues, and bifunctional probes where hydrophilic spacing improves solubility and modulates PK-like properties in research systems.
    • Surface modification of nanoparticles, resins, and microarrays to reduce nonspecific binding via PEGylation, while reserving a protected amine for subsequent coupling.
    • Precursor to amine-terminated PEG (after Boc removal) for amide, urea, thiourea, or sulfonamide formation with acids, isocyanates, and sulfonyl chlorides.
    • Hydroxyl activation to electrophiles (mesylate/tosylate/carbonate), enabling nucleophilic substitution to install azides, halides, thiols, or additional handles (e.g., alkyne/azide for click chemistry).
  • Practical tips

    • Keep reactions anhydrous to improve yields in activation steps (e.g., use 3Å molecular sieves, dry solvents).
    • Monitor reactions by 1H NMR integration of end-group signals or by MALDI-TOF to observe mass shifts across the oligomer envelope.
    • For conjugations to amines post-deprotection, buffer at pH 7.5–8.5 to balance nucleophilicity and minimize side reactions.
    • Purification: Precipitation into cold diethyl ether/MTBE or dialysis (for higher MW) can be effective; SEC or reverse-phase prep HPLC may be needed for high purity.

This item is intended for research use only.

Reaction Conditions

The following conditions are general literature guidance for PEG linkers with –OH and Boc‑protected amine termini; they are not specifications for this item.

  • Boc deprotection (to give H2N–PEG20–OH)

    • Typical: TFA/DCM (1:1 to 9:1 v/v), 0–25°C, 0.5–2 h. Monitor by 1H NMR (loss of Boc tBu) or LC/MS. Quench and remove volatiles under reduced pressure; neutralize with non-nucleophilic base (e.g., DIPEA) as needed during workup.
    • Alternative: 4 M HCl in dioxane, 0–25°C, 1–3 h, affording the ammonium chloride salt.
  • Hydroxyl activation to mesylate/tosylate

    • MsCl (1.1–1.5 equiv) or TsCl (1.2–1.5 equiv), Et3N or DIPEA (2–3 equiv), catalytic DMAP, in DCM or pyridine, 0°C to RT, 1–6 h. Keep anhydrous to suppress hydrolysis.
  • Carbonate formation (e.g., with CDI)

    • CDI (1.2–1.5 equiv), catalytic DMAP in anhydrous DCM/THF, 0–25°C, 1–3 h to form imidazolyl carbonate, then couple with amines/phenols (1.1–1.5 equiv) at RT.
  • Williamson etherification

    • Generate alkoxide with NaH (60% dispersion, 1.1–1.5 equiv) in dry DMF/THF at 0–25°C; add alkyl halide (1.1–1.5 equiv); stir 2–16 h. Quench cautiously and purify by precipitation or chromatography.
  • Post-deprotection amide coupling

    • With activated esters (NHS-esters): pH 7.5–8.5 in aqueous buffer with 5–20% DMF/DMSO, 0–25°C, 0.5–4 h. For carbodiimide couplings: EDC (1.1–1.5 equiv), NHS (1.1–1.5 equiv), pH ~5.5 for activation then adjust to pH ~7.5–8.0 for coupling.

Yields depend on substrate solubility and end-group integrity; verify by NMR and MS.

Safety and Handling
  • Item-specific hazard data (from Product Data)

    • GHS Classification: Not specified for this item; refer to SDS.
    • Signal Word: Not specified for this item; refer to SDS.
    • H-Statements: Not specified for this item; refer to SDS.
    • Pictograms: Not specified for this item; refer to SDS.
  • General safety considerations (literature/general; not product specifications)

    • PEG oligomers are generally regarded as low acute hazard; however, handle as a chemical of unknown toxicity. Avoid inhalation of aerosols, ingestion, and skin/eye contact.
    • Boc carbamates are acid labile. Contact with strong acids can release tert-butanol, isobutylene, and CO2; perform acid-mediated deprotections in a fume hood and vent CO2 evolution.
    • Incompatibilities: Strong acids (deprotect Boc), strong bases (may promote elimination or carbonate formation under certain conditions), strong oxidizers (may degrade PEG backbone).
    • Thermal decomposition can produce irritating vapors (COx, NOx from carbamate cleavage). Do not overheat; avoid hot plates set above required processing temperatures.
  • PPE and handling

    • Use lab coat, safety glasses, and suitable chemical-resistant gloves (e.g., nitrile). Work in a chemical fume hood when weighing, dissolving, or performing reactions.
    • Hygroscopic tendency is common for PEGs; keep containers tightly closed. Purge with inert gas after use when possible.
  • First-aid (overview; defer to SDS)

    • Skin/eye contact: Rinse with water for 15 minutes; remove contaminated clothing.
    • Inhalation: Move to fresh air; seek medical attention if symptoms persist.
    • Ingestion: Rinse mouth; do not induce vomiting; seek medical advice.

Always consult the SDS for authoritative safety and regulatory information.

Solvent Selection

Hydroxy-PEG20-Boc is amphiphilic: the PEG chain confers water compatibility, while the Boc carbamate increases organic solubility.

  • Polarity and miscibility (literature/general)

    • Excellent solubility in polar aprotic solvents (DMSO, DMF, NMP, MeCN) and polar protic solvents (MeOH, EtOH).
    • Often soluble in water at moderate concentrations; solubility improves with temperature and salt-free conditions.
    • Poor solubility in alkanes and many nonpolar aromatics; can be co-dissolved using minimal DCM/THF with DMF/NMP as cosolvent.
  • Selection guidance by operation

    • Boc deprotection: DCM or DCM/TFE, with TFA as acid (typical systems). For aqueous workups, DCM enables easy phase separation.
    • End-group activation (e.g., carbonate formation): Anhydrous DCM, THF, or DMF with base (e.g., pyridine, DIPEA) and catalytic DMAP.
    • Nucleophilic substitutions from mesylate/tosylate intermediates: Dry DMF/DMSO favored; maintain low water content to suppress hydrolysis.
    • Bioconjugation to biomolecules post-deprotection: Aqueous buffers (pH 7.5–9) with co-solvents (≤20% DMF/DMSO) to maintain solubility while preserving biomolecule integrity.
  • Brief comparison (general)

    • DCM: Excellent for Boc chemistry and chlorocarbonate activations; volatile and halogenated—handle in hood.
    • THF/2-MeTHF: Good for base-mediated steps; consider peroxide testing for stored THF.
    • DMF/DMSO: Superior solubility for high-MW PEGs; higher boiling points complicate removal.
    • Water: Valuable for late-stage conjugation; may require co-solvents to avoid phase separation.

Choose solvents based on step requirements, solubility, and downstream purification strategy.

Storage and Reconstitution
  • Item-specific instructions (from Product Data)

    • Storage Conditions: Store at -20°C.
    • Shipped In: Ice chest + Ice pads.
  • General handling guidance for PEG linkers (literature/general)

    • Protect from moisture and acids. Boc groups are acid labile; minimize exposure to acidic vapors and silica gel containing residual acid. If long-term storage on silica is necessary, pre-neutralize or use neutral alumina for brief operations.
    • Allow the sealed container to warm to room temperature before opening to prevent moisture condensation. Reseal promptly; purge headspace with inert gas if available.
    • Hygroscopic/viscous materials benefit from aliquoting on receipt to minimize freeze–thaw and air exposure. Use dry spatulas and syringes for transfer.
    • For solution storage, prepare anhydrous stock solutions (e.g., in dry DCM, THF, or DMF) under inert atmosphere and keep at −20°C; verify stability of Boc under chosen solvent/storage.
  • Reconstitution

    • Dissolves readily in polar organic solvents (DMF, DMSO, MeOH, EtOH) and often in water; choose solvent compatible with the next synthetic step. Filter if particulates are present (PTFE syringe filter, 0.45 µm).

Always refer to the CoA/Spec Sheet for any item-specific stability data and the SDS for safe handling during storage and use.

Structure and Identity

Hydroxy-PEG20-Boc is a heterobifunctional polyethylene glycol (PEG) linker featuring a terminal hydroxyl group and a Boc-protected amine at the opposite terminus.

  • Item-specific identifiers (from Product Data)

    • SKU: H1447200
    • CAS: Not specified for this item; refer to CoA/Spec Sheet.
    • InChIKey: Not specified for this item; refer to CoA/Spec Sheet.
    • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
  • Structural features (general/literature description)

    • Backbone: Approximately 20 ethylene glycol repeat units [–CH2–CH2–O–]n (n≈20), yielding an average, polydisperse oligomeric chain.
    • End-groups: One terminus is a primary alcohol (–OH); the other terminus is a tert‑butoxycarbonyl (Boc) protected amine (–NH–COOtBu), i.e., Boc‑NH–PEG20–OH.
    • Functional group taxonomy: Polyether backbone; terminal alcohol; carbamate (Boc) protecting group masking a primary amine.
    • Stereochemistry: None (achiral repeating ether units; no defined stereocenters).
    • Dispersity: PEG oligomers typically exhibit a narrow but finite molar mass distribution (Ð > 1); exact dispersity for this item is not specified.
  • 2D structure (descriptive)

    • A linear chain of alternating –CH2–CH2– and –O– units (≈20 repeats), capped at one end with –OH and at the other with –NH–COOtBu (Boc). This arrangement enables orthogonal chemistry: acid-labile Boc protection on the amine while leaving the hydroxyl available for independent transformations.
Synthetic Utility

Hydroxy-PEG20-Boc is a modular, orthogonally protected linker enabling diverse transformations on each terminus.

  • Hydroxyl terminus (literature/general)

    • Activation: Convert –OH to mesylate/tosylate (MsCl or TsCl, base, DMAP) or to activated carbonates (e.g., CDI, p-nitrophenyl chloroformate) for subsequent displacement by amines, thiols, or azide.
    • Direct transformations: Esterification (DCC/DMAP or EDC/DMAP), etherification via Williamson protocol (alkoxide from NaH/KOtBu) to introduce reporter groups (alkyne, azide, fluorophores).
  • Boc-protected amine terminus

    • Orthogonality: Boc resists many neutral/basic conditions, allowing independent chemistry at the hydroxyl end.
    • Deprotection: Acid-labile (TFA, HCl in dioxane) to reveal primary amine for amide couplings (with activated acids), urea formation (with isocyanates or CDI-activated carbonates), or sulfonamide formation (with sulfonyl chlorides).
  • Retrosynthetic value

    • Serves as a hydrophilic spacer in PROTACs, ADC-mimics (research), and affinity probes. The PEG20 length balances flexibility with aqueous compatibility.
  • Analytical control

    • Track conversions by 1H NMR end-group signals (tBu singlet ~1.4 ppm for Boc; disappearance upon deprotection), SEC/GPC for dispersity, and MALDI-TOF mass shifts corresponding to end-group changes.

These features make Hydroxy-PEG20-Boc a robust building block for assembling multifunctional, water-compatible constructs in research synthesis.

Target Specificity

Not applicable. This product is a small-molecule PEG linker and does not have antigen/epitope targets, species reactivity, clone, or isotype. For application-relevant details, see Reaction & Applications and Synthetic Utility.

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.